Application Note: Comprehensive biosimilar comparability assessment via intact and subunit RP-MS and IEX-UV-MS using the Xevo G3 QTof system
20 June 2022

In this application note, Waters demonstrates the use of Xevo™ G3 QTof platform to perform a comparability analysis for infliximab innovator Remicade® and three biosimilars (Inflectra®, Avsola®, and Renflexis®).

Company